Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 9 - Medicinal preparations characterised by special physical form
Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
12/2007
12/21/2007WO2007095043A3 Pharmaceutical formulations
12/21/2007WO2007090082A3 Drug delivery systems comprising weakly basic selective serotonin 5-ht3 blocking agent and organic acids
12/21/2007WO2007076448A3 Pharmaceutical composition for delivery of receptor tyrosine kinase inhibiting (rtki) compounds to the eye
12/21/2007WO2007047327A3 Methods and articles for treating 25-hydroxyvitamin d insufficiency and deficiency
12/21/2007WO2007025005A3 Sustained release formulations of nalbuphine
12/21/2007WO2003082204A3 Sustained-release gel coated compositions
12/21/2007WO2002072068A3 Lipids, lipid compositions, liposomes, and lipoplexes
12/21/2007CA2836545A1 Pharmaceutical composition
12/21/2007CA2682755A1 Fermented plant extracts, methods of production and uses
12/21/2007CA2660647A1 A suspension comprising benzimidazole carbamate and a polysorbate
12/21/2007CA2656672A1 Methods for the formulation and manufacture of artesunic acid for injection
12/21/2007CA2654990A1 Pharmaceutical formulations and compositions of a selective antagonist of either cxcr2 or both cxcr1 and cxcr2 and methods of using the same for treating inflammatory disorders
12/21/2007CA2654909A1 Nanoparticulate kinase inhibitor formulations
12/21/2007CA2654890A1 Pharmaceutical composition
12/21/2007CA2654592A1 System for monitoring of patients
12/21/2007CA2654477A1 Smoking withdrawal combination wafer
12/21/2007CA2654211A1 Combination antihypertensive wafer
12/21/2007CA2654207A1 Insulin composition
12/21/2007CA2654111A1 Oral pharmaceutical composition of a poorly water-soluble active substance
12/21/2007CA2654041A1 Stable aerosol pharmaceutical formulations
12/21/2007CA2653782A1 Topical compositions
12/21/2007CA2653047A1 Type-2 diabetes combination wafer
12/21/2007CA2653030A1 Ache-nmda combination wafer
12/21/2007CA2652515A1 Opioid combination wafer
12/21/2007CA2652476A1 Combination antidepressants wafer
12/21/2007CA2649361A1 Methods to administer solid dosage forms of ethinyl estradiol and prodrugs thereof with improved bioavailability
12/21/2007CA2646980A1 Compositions comprising porphyra and methods of making and using thereof
12/21/2007CA2550753A1 Liquid vitamin and supplement formulations
12/20/2007US20070293823 Implantable Vascular Access Device
12/20/2007US20070293576 Pharmaceutical Methods, Dosing Regimes And Dosage Forms For The Treatment Of Alzheimer's Disease
12/20/2007US20070293564 Dimeric compounds and their use as anti-viral agents
12/20/2007US20070293557 Anticancer compositions, and methods of making and using the same
12/20/2007US20070293469 Compositions and methods for the treatment and prevention of disease
12/20/2007US20070293468 Reacting indazolium hydrochloride with Sodium tetrachlorobisindazoleruthenate(III) to form trans-Indazolium [tetrachlorobisindazoleruthenate(III)] (KP1019), and sodium chloride; both highly effective and water soluble; bioavailability; cancer treatment
12/20/2007US20070293447 Gene Therapy for Skin Disorders Using Needleless Syringes
12/20/2007US20070293419 Stable, Aqueous Solution of Human Erythropoietin, Not Containing Serum Albumin
12/20/2007US20070292687 Microcapsule with Controllable or Delayed Release for the Immobilization of Chemical and/or Biological Materials, and Method for the Production Thereof
12/20/2007US20070292526 Combining a reverse micelle solution with silica-, alumina-, titanium dioxide-, iron oxide-, and/or zirconium dioxide-based gel precursor solution containing catalyst, a condensation agent (H2O), and polar solvent, one of which contains an active material, to generate droplets containing active material
12/20/2007US20070292525 Controlled release ceramic particles, compositions thereof, processes of preparation and methods of use
12/20/2007US20070292524 Delivery vehicle containing nanoparticles
12/20/2007US20070292523 Dihydropyrimidine Formulations
12/20/2007US20070292522 Method for forming microcapsules with multiple shell layers
12/20/2007US20070292521 Oral Encapsulated Preparation for Aquatic Animals
12/20/2007US20070292520 Pulmonary Insulin Crystals
12/20/2007US20070292519 Method of producing a nicotine medicament and a medicament made by the method
12/20/2007US20070292518 Nanoshell therapy
12/20/2007US20070292517 Delivery Systems for Antacids
12/20/2007US20070292516 Multifunctional biocompatible hydrophilic gel and the method of gel manufacture
12/20/2007US20070292515 Solid dosage form containing a taste masked active agent
12/20/2007US20070292513 Pazopanib hydrochloride and synthesis, chemical intermediates, and dosage forms thereof; anticancer; colon cancer, breast cancer
12/20/2007US20070292512 Solid Oral Dosage Form Containing an Enhancer
12/20/2007US20070292511 Duloxetine hydrochloride delayed release formulations
12/20/2007US20070292510 Enteric coated particles containing an active ingredient
12/20/2007US20070292509 Enteric coated granule and method for preparing the same
12/20/2007US20070292508 Orally disintegrating dosage forms
12/20/2007US20070292507 Supportive Treatment of Liver Disease
12/20/2007US20070292506 Sustained release formulations
12/20/2007US20070292505 Controlled release alfuzosin hydrochloride formulation
12/20/2007US20070292504 Pharmaceutical formulation containing a release rate controlling composition
12/20/2007US20070292503 Oral pharmaceutical composition of poorly water-soluble active substance
12/20/2007US20070292502 Chitosan-Embedded or Encapsulated Capsule
12/20/2007US20070292501 Chewable soft gelatin capsules
12/20/2007US20070292500 Novel Extended Release Composition of Venlafaxine Hydrochloride Containing Polyvinyl Acetate
12/20/2007US20070292499 Processes for the Preparation of Solid Dosage Forms of Amorphous Valganciclovir Hydrochloride
12/20/2007US20070292498 Combinations of proton pump inhibitors, sleep aids, buffers and pain relievers
12/20/2007US20070292497 Method for treating micrometastatic tumors
12/20/2007US20070292496 Formulation of liposomal vesicles in aqueous solutions with lachrymal film characteristics
12/20/2007US20070292495 Nanoshells for drug delivery
12/20/2007US20070292494 Carbohydrate-Derivatized Liposomes for Targeting Cellular Carbohydrate Recognition Domains of Ctl/Ctld Lectins, and Intracellular Delivery of Therapeutically Active Compounds
12/20/2007US20070292491 Adhesive Patch
12/20/2007US20070292487 Anti-Inflammatory Dissolvable Film
12/20/2007US20070292486 Novel polymer-nano/microparticle composites
12/20/2007US20070292477 Association of Antimicrobial Compounds with Surfaces and Polymers
12/20/2007US20070292475 Controlled release microparticles
12/20/2007US20070292473 Device for local administration of solid or semi-solid formulations and delayed-release formulations for proposal parenteral administration and preparation process
12/20/2007US20070292463 Compositions and methods comprising energizable particles for health use
12/20/2007US20070292462 Surfactant, and an emulsion-type cosmetic composition and a liposome containing said surfactant
12/20/2007US20070292460 Product release system to atomize non-liquid or highly viscous cosmetic compositions
12/20/2007US20070292459 Halloysite microtubule processes, structures, and compositions
12/20/2007US20070292457 Electrical Nutritional Supplement
12/20/2007US20070292456 Formulations Containing an Immune Response Modifier
12/20/2007US20070292454 Therapeutic calcium phosphate particles and methods of manufacture and use
12/20/2007US20070292413 Comprised of three lipid elements: phosphatidyl choline, fatty-acyl-cholesterol esters, and at least one apolipoprotein; brain disorders; kits; efficiently target and deliver substances
12/20/2007US20070292361 Encapsulation compositions
12/20/2007US20070292359 Polypropylene glycol foamable vehicle and pharmaceutical compositions thereof
12/20/2007US20070292357 Biphenyl compounds useful as muscarinic receptor antagonists
12/20/2007US20070292356 Biphenyl compounds useful as muscarinic receptor antagonists
12/20/2007US20070292355 Alcohol-free drug or cosmetics carrier mixture of water, hydrophobic solvent, surfactant and gelling agent; oil in water emulsions
12/20/2007US20070290384 Gas dispersion manufacture of nanoparticulates, and nanoparticulate-containing products and processing thereof
12/20/2007US20070289070 Additive For Domestic Washing Processes
12/20/2007DE102007026969A1 Verfahren zur Herstellung einer diffraktiven Gitter-Mikrostruktur auf der Oberfläche einer Tablette A process for producing a diffractive grating microstructure on the surface of a tablet
12/20/2007DE102007026957A1 Pharmaceutical tablet with a diffractive microstructure comprises a mass of single powder particles
12/20/2007DE102006027796A1 Flat form medicament preparation based on hydrophilic polymer disintegrates quickly in contact with moisture, useful e.g. to release active agent in body opening/body cavity e.g. for contraception, comprises active agent combination
12/20/2007DE102006027795A1 Raucherentwöhnungs-Kombinationswafer Smoking cessation combination wafer
12/20/2007DE102006027794A1 Antihypertonie-Kombinationswafer Antihypertensive combination wafer
12/20/2007DE102006027791A1 AchE-NMDA-Kombinationswafer AchE NMDA combination wafer
12/20/2007DE102006027790A1 Typ-2-Diabetes Kombinations-Wafer Type 2 diabetes combination wafer
12/19/2007EP1867472A2 Composite material and method for manufacturing such composite material
12/19/2007EP1867334A1 Method of relieving or avoiding side effect of steroid compound
12/19/2007EP1867333A1 Pharmaceutical composition comprising condensed indole compound
1 ... 1320 1321 1322 1323 1324 1325 1326 1327 1328 1329 1330 1331 1332 1333 1334 1335 1336 1337 1338 1339 1340 ... 2991